<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548076</url>
  </required_header>
  <id_info>
    <org_study_id>20-KAEK-076</org_study_id>
    <nct_id>NCT04548076</nct_id>
  </id_info>
  <brief_title>Thoracolumbar Interfascial Plane Block in Vertebral Surgery</brief_title>
  <official_title>Investigation of Analgesic Efficacy of Thoracolumbar Interfascial Plane Block in Vertebral Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokat Gaziosmanpasa University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tokat Gaziosmanpasa University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the postoperative analgesic efficiency of thoracolumbar interfascial plane block&#xD;
      , patients are divided into two groups. Study group received ultrasound-guided thoracolumbar&#xD;
      interfascial plane block , where control had none. Visual analog scale and opioid consumption&#xD;
      are recorded.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thoracolumbar interfascial plane block has successfully been demonstrated to provide an&#xD;
      efficient analgesia in patients. The present study is aimed to investigate the intraoperative&#xD;
      hemodynamic responses, anesthetic and analgesic consumption, and postoperative recovery&#xD;
      quality of thoracolumbar interfascial plane block in patients with vertebral surgery. After&#xD;
      approval, patients enrolled in the study are divided into two groups by computer-based&#xD;
      randomization technique as control and study group. After standard monitorization, anesthesia&#xD;
      induction and tracheal intubation, erector spinae plane block is performed to study group and&#xD;
      no intervention to control group.&#xD;
&#xD;
      In the intraoperative period, 10 mg / kg paracetamol and 0.05 mg / kg morphine will be used&#xD;
      for postoperative analgesia. After surgery, all patients will be given 10 mg/kg paracetamol&#xD;
      every 8 hours and will be fitted with a patient-controlled analgesia (PCA) device (Tramadol&#xD;
      HCL). PCA device bolus dose will be set to 20 mg, lock time will be set to 10 minutes and the&#xD;
      number of buttons per hour will be set as 3.for postoperative analgesia.After surgery, VAS&#xD;
      scores of the patients will be evaluated (in the recovery room, 1,3,6,12 and 24 hours,&#xD;
      Patients with VAS&gt;4 will be given 0.03mg / kg morphine as salvage analgesia.After 30 minutes,&#xD;
      the patients' VAS will be re-evaluated,If VAS&gt;4 the same dose will be repeated. A patient&#xD;
      satisfaction questionnaire (Qr40)will be filled by patients at the postoperative 24th hour.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2020</start_date>
  <completion_date type="Anticipated">September 7, 2021</completion_date>
  <primary_completion_date type="Actual">August 21, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale</measure>
    <time_frame>one time in postoperative period for one year</time_frame>
    <description>Visual analog scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>During postoperative period for one yea</time_frame>
    <description>Opioid consumption</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Block</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Block group</intervention_name>
    <description>Control group</description>
    <other_name>Patients received thoracolumbar interfascial plane block before operation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Vertebral surgery patients who will be operated under general anesthesia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Over 18 years of age, Planned to vertebral surgery, An American Society of&#xD;
        Anesthesiologists score of 1,2 or 3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Severe cardiovascular disease, Psychiatric diseases, Rejected to participation, Those who&#xD;
        have chronic pain&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hakan Tapar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gaziosmanpasa University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hakan Tapar</last_name>
    <phone>03562129500</phone>
    <phone_ext>3495</phone_ext>
    <email>hakantapar@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Serkan Karaman</last_name>
    <phone>03562129500</phone>
    <phone_ext>3495</phone_ext>
    <email>serkankaraman52@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gaziosmanpasa University</name>
      <address>
        <city>Tokat</city>
        <zip>60200</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hakan Tapar, Assist.Prof.</last_name>
      <phone>+905056844496</phone>
      <email>hakantapar@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>August 21, 2021</last_update_submitted>
  <last_update_submitted_qc>August 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokat Gaziosmanpasa University</investigator_affiliation>
    <investigator_full_name>Hakan Tapar</investigator_full_name>
    <investigator_title>Tokat Gaziosmanpasa University</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

